Basecamp Wealth Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.64K Sell
77
-142
-65% -$7.3K ﹤0.01% 1237
2026
Q1
$13K Hold
219
﹤0.01% 945
2025
Q4
$13.5K Buy
+219
New +$13.4K ﹤0.01% 890

Other funds holding PBH

Basecamp Wealth Advisors's PBH Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 65% in Q2 2026, selling an estimated $7.3K and leaving 77 shares worth $3.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1237.

Basecamp Wealth Advisors first reported a position in PBH in Q4 2025 and has held it in 3 quarters since. The position peaked at $13.5K in Q4 2025. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Basecamp Wealth Advisors held 77 shares of Prestige Consumer Healthcare worth $3.64K as of Q2 2026.
  • Basecamp Wealth Advisors sold 142 Prestige Consumer Healthcare shares in Q2 2026, an estimated $7.3K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1237 holding.
  • Basecamp Wealth Advisors first reported a position in Prestige Consumer Healthcare in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Prestige Consumer Healthcare position peaked at $13.5K in Q4 2025.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.